2005
DOI: 10.1002/cncr.21225
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions

Abstract: BACKGROUNDTumor perfusion through the microvascular network can be imaged noninvasively by dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI). The objective of the current study was to quantify the microvascular perfusion parameters in various human breast lesions and to determine whether they varied between benign lesions and malignancy and whether they were altered with increased invasiveness.METHODSPerfusion parameters in 22 benign fibrocystic changes, 15 ductal carcinomas in situ (DCIS), 30 inf… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

6
63
0
9

Year Published

2006
2006
2011
2011

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 89 publications
(78 citation statements)
references
References 49 publications
6
63
0
9
Order By: Relevance
“…Aggressive tumors are known to have a high angiogenic activity, which is essential to maintain a sufficient blood supply to the highly proliferative tumor cells. DCE-MRI is a promising tool for functional in vivo assessment of tumor vascularity (13). In this study gadodiamide was selected as the contrast agent, since it is widely used in clinical practice.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Aggressive tumors are known to have a high angiogenic activity, which is essential to maintain a sufficient blood supply to the highly proliferative tumor cells. DCE-MRI is a promising tool for functional in vivo assessment of tumor vascularity (13). In this study gadodiamide was selected as the contrast agent, since it is widely used in clinical practice.…”
Section: Discussionmentioning
confidence: 99%
“…Dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) is used as a tool for in vivo characterization of tumor vasculature (10,11). Contrast enhancement kinetics obtained by DCE-MRI correlates with tumor type, histological grade, MVD, and biomarkers such as estrogen receptors (ER), progesterone receptors (PgR), and the proliferation marker Ki-67 (6,(12)(13)(14)(15)(16)(17). By using a pharmacokinetic two-compartment model, maps of tissue properties such as vascular permeability and perfusion (K trans ), extracellular extravascular volume fraction (v e ), and blood plasma volume fraction (v p ) can be obtained (18).…”
mentioning
confidence: 99%
“…The use of DCE-MRI for quantification of tumor vascularity, tumor staging, or treatment efficacy has been explored for cancers of the prostate 5,6 , colon 7 , liver 8 , breast 9 , and cervix. For the case of cervical cancer, the change in volume over the first 2-4 weeks of therapy has been shown to be related to treatment outcome 10 .…”
Section: Introductionmentioning
confidence: 99%
“…[2] O tumor tem alta demanda metabólica por oxigênio e nutrientes e ela aumenta à medida que há o crescimento tumoral. Isto causa hipóxia, levando a formação de novos vasos, processo denominado angiogênese [3,[9][10][11][12] .…”
Section: Introductionunclassified
“…Degani e colaboradores [12,20] desenvolveram um modelo usando RM com contraste, com alta resolução temporal e espacial, onde com modelos matemáticos de compartimentos como os padronizados por Tofts [21] , calcula a permeabilidade vascular e VEC das lesões. [20][21][22] Existem hoje muitos aplicativos com uso de RM com contraste dinâmico para medir estes parâmetros biológicos, sendo um deles o método Full Time Point (FTP) (Cadsciences; White Plains, NY, USA), que é um sistema de detecção assistida por computador (CAD), que baseado na metodologia de Degani [20] , calcula a permeabilidade e VEC para cada pixel da lesão, traduzido em um gráfico de cores.…”
Section: Introductionunclassified